Pfizer informs about issuance of duplicate share certificates

Pfizer Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 500680 | NSE: PFIZER

04 Jun 2021 Evaluate

Pursuant to Regulation 39(3) and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pfizer has informed that the Registrar and Transfer Agent of the Company, KFin Technologies has received requests for issue of duplicate Share Certificate(s) from the Shareholders. Details enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1850.30
Dr. Reddys Labs.	1210.25
Cipla	1375.40
Lupin	2094.25
Zydus Lifesciences	1162.50
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.